MEIP Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 birž. 2024 @ 23:00):
Our systems believe the stock currently is overvalued by -2.17% compare to its pairs and should correct downwards.

MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer...

Stats
Šios dienos apimtis	7 782
Vidutinė apimtis	19 111
Rinkos kapitalizacija	19.19M
EPS	$-1.370 ( Q3 \| 2024-05-09 )
Last Dividend	$1.750 ( 2023-11-16 )
Next Dividend	$0 ( N/A )
P/E	0.730 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0180 (0.64%)

AADI 0.00%

ABCL 0.98%

ABCM 0.04%

ABEO 0.22%

ABIO 2.17%

ABOS -0.40%

ABSI 0.00%

ABUS 0.33%

ABVX -0.22%

ACAD 0.84%

ACER -17.95%

ACET 0.38%

ACGN 1.29%

ACHL -2.44%

ACHV 1.63%

ACIU 0.00%

ACLX 0.28%

ACRV 0.73%

ACST 0.62%

ACXP 1.68%

ADAG -5.64%

ADAP -0.93%

ADGI 0.87%

ADIL -1.57%

ADMA 0.25%

ADPT -0.96%

ADTX -1.27%

ADVM -0.07%

ADXN -6.11%

AEON 11.51%

AEZS -5.44%

AFMD -0.59%

AGEN -3.22%

AGIO 0.56%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW 53.45%

AKBA -0.95%

AKRO 0.26%

AKTX -2.70%

AKUS 0.00%

ALBO 0.00%

ALDX 1.90%

ALEC 0.44%

ALGS -0.25%

ALKS 0.34%

ALLK -0.85%

ALLO -0.67%

ALLR -2.32%

ALNA 3.16%

ALNY -0.01%

ALPN 0.00%

ALPX 0.00%

ALRN -0.31%

ALT -0.34%

ALVR 0.60%

ALXN 0.00%

ALXO -1.49%

ALZN 0.00%

AMRN -0.52%

AMTI -3.13%

ANAB -0.94%

ANEB -5.58%

ANGN 0.00%

ANIX -1.15%

ANL 0.61%

ANNX -0.65%

ANPC -3.15%

APGE 0.36%

APGN 8.48%

APGNW 30.65%

APLM 10.18%

APLS 0.78%

APLT 0.21%

APM 1.33%

APOP 0.38%

APRE 2.44%

APTO 0.68%

APTX 3.17%

APVO -0.02%

ARAV -13.39%

ARCT -0.44%

ARDS 20.48%

ARDX 0.08%

ARGX 0.19%

ARNA 0.00%

ARPO -0.90%

ARQT -1.51%

ARTL -4.55%

ARTLW 9.80%

ARVN -0.60%

ARWR -0.87%

ASLN 2.75%

ASMB -0.86%

ASND 0.41%

ATAI 0.37%

ATHA -0.38%

ATHE -1.61%

ATHX -33.50%

ATNF -4.37%

ATOS 0.87%

ATRA -2.10%

ATXI -1.66%

ATXS 0.45%

AUPH -0.36%

AURA 0.68%

AUTL -0.23%

AVBP -0.27%

AVEO 0.00%

AVIR -0.28%

AVRO -2.05%

AVTE -4.26%

AVTX 4.15%

AVXL 0.00%

AXLA 0.00%

AXSM 0.07%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.44%

BCAB 1.92%

BCDA -0.30%

BCDAW -33.33%

BCEL -1.32%

BCLI -0.73%

BCRX -1.44%

BCTX -0.68%

BCTXW 0.00%

BCYC 1.49%

BDRX 1.05%

BDTX -0.55%

BEAM -0.12%

BFRA -2.91%

BGNE -1.47%

BIOR 0.03%

BIVI 1.73%

BLCM -6.68%

BLI -5.88%

BLPH -0.79%

BLRX 2.36%

BLTE -0.72%

BLU 0.03%

BLUE -1.19%

BMEA -0.39%

BMRN 0.40%

BNOX -3.57%

BNTC 2.46%

BNTX -0.16%

BOLD 0.49%

BOLT -0.50%

BPMC 0.12%

BPTH 1.26%

BPTS -13.47%

BRNS 2.96%

BRTX -9.80%

BTAI 0.75%

BTTX -7.50%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 0.00%

CABA -1.41%

CADL -1.11%

CALA 60.00%

CALC -1.62%

CALT -0.64%

CAPR -0.60%

CARA 2.85%

CARM 0.97%

CASI -2.41%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 2.61%

CCCC -1.09%

CCXI 0.00%

CDAK 0.00%

CDIO -3.01%

CDIOW 0.00%

CDMO -0.40%

CDMOP 0.04%

CDT -6.11%

CDTTW 294.32%

CDTX -0.08%

CDXC -1.18%

CDXS -1.51%

CELC 0.99%

CELU 7.05%

CELUW -9.52%

CERC -1.68%

CERE 0.07%

CERO -4.29%

CEROW -44.78%

CFRX -27.95%

CGEM -1.87%

CGEN -1.02%

CGON -0.59%

CGTX 1.37%

CHMA -6.00%

CHRS -0.01%

CINC 0.00%

CING 4.48%

CINGW -48.24%

CKPT -0.49%

CLBS -16.75%

CLDX 2.83%

CLGN 0.30%

CLLS -6.54%

CLNN 0.37%

CLNNW -41.25%

CLRB 0.74%

CLSD 0.86%

CLSN -0.68%

CLVS 0.00%

CMMB 10.18%

CMND 3.65%

CMPI 0.00%

CMPX 0.00%

CMRA 0.40%

CMRAW 33.33%

CMRX 1.11%

CNCE 0.00%

CNSP -5.00%

CNST 0.00%

CNTA 0.31%

CNTB 3.13%

CNTX -1.03%

COCP 0.42%

COEPW -0.66%

COGT -0.11%

CORT -0.28%

COYA 2.22%

CPRX 0.00%

CRBP -2.67%

CRBU -0.57%

CRDF -0.75%

CRGX 0.00%

CRIS 0.73%

CRNX -0.55%

CRSP 0.10%

CRTX 2.63%

CRVO 1.97%

CRVS 0.00%

CSBR 1.19%

CTCX -8.04%

CTIC 0.06%

CTMX 2.16%

CTNM -2.94%

CTXR 1.43%

CUE -0.75%

CVAC 0.86%

CVKD 1.37%

CWBR -2.55%

CYAD -12.96%

CYCC -2.45%

CYCCP -1.79%

CYCN 6.00%

CYT -2.27%

CYTK -0.37%

CYTO -3.23%

DARE 1.19%

DAWN 0.54%

DBTX -0.81%

DBVT 1.01%

DFFN 10.28%

DICE 0.06%

DMAC -0.42%

DNLI 1.12%

DNTH 0.04%

DOMH 1.99%

DRMA 0.00%

DRMAW 0.00%

DRNA 0.00%

DRTS -1.32%

DRTSW 1.01%

DRUG 0.00%

DSGN 0.26%

DTIL -1.19%

DYAI -5.29%

EARS -1.77%

EDIT 4.14%

EDSA 1.04%

EFTR -3.13%

EFTRW -0.26%

EIGR 0.00%

ELAB -2.87%

ELDN 0.71%

ELEV -0.84%

ELOX -12.50%

ELTX -2.33%

ELVN -0.65%

ELYM 0.52%

ENGN -3.89%

ENGNW -5.29%

ENLV 0.73%

ENOB 1.79%

ENSC 0.88%

ENTA -0.75%

ENTO 0.48%

ENTX 1.45%

ENVB 3.24%

EPIX 0.00%

EPRX -0.19%

EPZM 0.00%

EQ 1.40%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.49%

ERNA 4.79%

ERYP 1.30%

ESLA 1.14%

ESLAW -9.25%

ETNB -0.45%

ETON 1.19%

ETTX 0.00%

EVAX 4.45%

EVGN -2.55%

EVLO 50.00%

EWTX -0.58%

EXAI 0.00%

EXEL 0.00%

EYEG -0.43%

EYEN -0.33%

EYPT -1.33%

FATE 0.42%

FBIO 0.53%

FBIOP 1.09%

FBLG -1.17%

FBRX -7.46%

FDMT -0.67%

FENC 0.74%

FGEN 0.47%

FHTX 9.52%

FIXX 0.77%

FMTX 0.00%

FNCH -6.25%

FOLD -0.20%

FREQ 4.76%

FRLN 0.15%

FRTX -0.54%

FSTX 0.00%

FTRE 0.58%

FULC 0.00%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 3.20%

GANX -0.38%

GBIO 1.37%

GBT 0.01%

GDTC -7.21%

GERN -1.06%

GHRS 3.42%

GLMD -3.30%

GLPG 0.93%

GLSI -2.51%

GLTO 0.00%

GLUE 0.00%

GLYC 2.57%

GMAB 0.95%

GMDA 0.00%

GMTX 0.00%

GNCA -85.71%

GNFT 0.97%

GNLX 0.00%

GNPX 1.84%

GNTA 0.00%

GOSS 11.38%

GOVX 18.92%

GOVXW -24.72%

GPCR 0.40%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -1.42%

GRTX -4.26%

GTHX 0.38%

GUTS 0.28%

GXGXW 41.67%

GYRE 0.17%

HALO -0.01%

HARP 0.09%

HCWB -9.73%

HEPA -6.36%

HGEN -84.62%

HILS 5.66%

HLVX 0.00%

HOOK 0.56%

HOTH -3.73%

HOWL -1.27%

HRMY 0.00%

HRTX 1.66%

HSTO 62.16%

HUMA 1.45%

HUMAW -5.97%

IBRX 0.85%

ICCC 2.84%

ICPT 0.21%

ICU -0.26%

ICUCW -10.39%

ICVX -0.91%

IDRA -23.04%

IDYA -0.13%

IFRX -3.21%

IGMS 0.14%

IKNA 1.15%

IKT 8.90%

IMAB -1.10%

IMCR -0.81%

IMGN 0.02%

IMGO 0.00%

IMMP 1.15%

IMMX -0.49%

IMNM -0.46%

IMNN -0.90%

IMPL -27.27%

IMRA 15.96%

IMRN -2.78%

IMRX 0.32%

IMTX -0.85%

IMTXW -2.70%

IMUX 1.75%

IMV 0.00%

IMVT 0.11%

INAB -0.02%

INBX -0.35%

INCY 0.46%

INDP -3.03%

INFI -52.38%

INKT -0.39%

INM 1.46%

INMB -0.60%

INO 0.00%

INSM -0.40%

INTS 0.84%

INVA 1.55%

INZY 0.44%

IOBT -0.81%

IONS -0.37%

IOVA -0.12%

IPA 0.00%

IPHA -10.64%

IPSC 0.95%

IRON -1.08%

ISEE 0.38%

ITOS -0.84%

ITRM -2.61%

IVA 2.64%

IVVD 0.00%

JAGX -0.26%

JANX -0.13%

JAZZ 0.06%

JNCE 0.00%

JSPR -0.08%

JSPRW 2.33%

JUNS 0.00%

JUNSW 0%

KA -5.56%

KALV -0.42%

KDNY 0.22%

KMPH -0.34%

KNSA -0.05%

KNTE -0.38%

KOD 0.00%

KPRX 8.51%

KPTI -0.28%

KRBP 4.17%

KRON 0.00%

KROS -1.56%

KRRO -0.63%

KRTX 0.03%

KRYS -0.18%

KTRA 8.99%

KTTA -2.85%

KTTAW 8.62%

KURA 1.02%

KYMR -0.38%

KYTX 0.70%

KZIA 8.44%

KZR 0.65%

LABP 0.57%

LBPH -0.98%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.19%

LENZ -1.30%

LEXX 2.73%

LEXXW -9.42%

LGND -0.46%

LGNDV 0.00%

LGVN -12.50%

LIAN 0.00%

LIFE 2.70%

LIPO -1.23%

LIXT 0.40%

LIXTW 27.74%

LJPC -0.32%

LMNL 0.12%

LOGC -0.72%

LPCN 2.99%

LPTX -0.25%

LQDA -0.23%

LRMR 1.19%

LSTA -4.97%

LTRN -2.24%

LUMO 0.00%

LVTX -1.42%

LXEO -1.05%

LXRX 0.87%

LYEL -0.45%

LYRA -1.26%

MACK 0.00%

MBIO 32.67%

MBRX -4.83%

MCRB -1.60%

MDGL 0.06%

MDNA -13.16%

MDWD 1.00%

MDXG 0.15%

MEIP 1.41%

MESO 2.07%

MGNX -3.01%

MGTA -7.74%

MGTX -1.14%

MGX 2.85%

MIRM 0.93%

MIRO 0.59%

MIST 2.96%

MITO 0.00%

MLEC -4.55%

MLECW 9.25%

MLND -5.36%

MLTX 0.09%

MLYS -0.66%

MNKD 0.00%

MNMD 1.14%

MNOV 0.00%

MNPR 3.39%

MOLN 2.88%

MOR -0.55%

MORF 1.34%

MREO 0.00%

MRKR -4.76%

MRNA -0.99%

MRNS 2.07%

MRSN 0.00%

MRTX -0.17%

MRUS -1.24%

MRVI 0.28%

MTCR -1.29%

MTEM 1.54%

MTP -18.50%

MURA -0.30%

MYMD -0.91%

NAMS 3.25%

NAMSW -7.61%

NAUT 1.17%

NBRV 0.71%

NBSE -1.56%

NBTX -6.05%

NCNA -1.64%

NERV 0.00%

NEXI -1.40%

NGM -1.28%

NGNE -3.95%

NKGN 0.78%

NKGNW 39.76%

NKTR -2.14%

NKTX -1.89%

NLSP 145.02%

NLSPW 6.21%

NMRA 1.29%

NMTR -42.97%

NOVN -24.84%

NRBO 0.45%

NRIX 4.28%

NRSN -4.95%

NRSNW 6.50%

NRXP 0.99%

NRXPW -15.65%

NRXS -6.06%

NTBL 2.92%

NTEC -12.45%

NTHI 0%

NTLA 0.00%

NTRBW -6.25%

NUVL -0.03%

NVAX -0.75%

NVCT 1.18%

NVIV -34.28%

NXTC 0.70%

NYMX -0.05%

OABI -0.47%

OABIW 13.46%

OBIO -0.87%

OBSV 0.00%

OCEA -2.99%

OCGN 3.73%

OCS -1.09%

OCUL -0.36%

OCUP 0.00%

ODT -4.27%

OKYO 0.00%

OLMA -0.47%

OMER 0.87%

OMGA 5.65%

ONCO 18.82%

ONCR -3.08%

ONCS 31.87%

ONCT -0.12%

ONCY -0.99%

ONTX -0.47%

ONVO -2.35%

OPNT 0.00%

OPT 0.80%

ORGS -1.72%

ORIC -0.13%

ORMP 0.00%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK 0.26%

OVID -3.75%

OYST 0.00%

PALI 0.86%

PASG -0.99%

PBLA 9.76%

PBM -0.02%

PBYI -0.63%

PCSA 5.71%

PCVX -0.73%

PDSB -0.37%

PEPG 0.70%

PGEN 0.61%

PHAR 2.17%

PHAS 0.00%

PHAT -0.60%

PHIO 6.80%

PHIOW 36.47%

PHVS -0.53%

PHXM -5.20%

PIRS -5.64%

PKBO 0.00%

PKBOW 999 900.00%

PLRX 0.27%

PLUR 0.00%

PMN 0.00%

PMVP 0.00%

PNT 0.16%

PPBT 2.78%

PRAX 5.56%

PRDS 0.93%

PRLD 0.77%

PROG -3.47%

PROK 1.03%

PRQR -1.76%

PRTA 0.34%

PRTC -0.72%

PRTG 6.52%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV 0.00%

PSTX 1.81%

PTCT 0.06%

PTE -0.82%

PTGX 0.03%

PTIXW 2.50%

PULM 3.72%

PXMD -1.92%

PYPD -0.36%

PYXS 0.00%

QLGN 19.02%

QNCX -1.41%

QNRX 3.04%

QSI 1.13%

QSIAW 0.00%

QTTB 0.00%

QURE -0.43%

RAIN -1.63%

RANI 0.00%

RAPT -0.30%

RARE -1.56%

RCKT 0.19%

REGN 0.06%

RENB -1.89%

REPL -0.13%

RETA 0.02%

REUN -0.89%

REVB 5.40%

REVBU 3.46%

REVBW 25.20%

RGLS 0.42%

RGNX 1.12%

RIGL 2.00%

RLAY 0.70%

RLMD 0.00%

RLYB 0.00%

RNA -1.02%

RNAC -1.07%

RNAZ 0.00%

RNXT 0.45%

ROIV 0.37%

ROIVW 4.56%

RPHM -0.60%

RPRX 0.68%

RPTX 1.58%

RUBY 2.70%

RVLP -32.05%

RVMD -0.16%

RVMDW -23.93%

RVNC -0.36%

RVPH -0.68%

RVPHW 11.54%

RXDX 0.09%

RXRX -0.32%

RYTM 0.46%

RYZB 0.02%

RZLT 0.00%

SABS -2.75%

SABSW -32.14%

SAGE 0.71%

SANA -0.17%

SAVA -0.80%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -10.34%

SCPH 0.00%

SCPS 0.00%

SEEL -1.16%

SEER -0.58%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -3.29%

SGMT -0.47%

SGTX -2.56%

SIOX 22.63%

SLDB -0.40%

SLGL -2.22%

SLN -1.55%

SLNO 0.38%

SLRX 5.16%

SLS -3.04%

SMMT -0.25%

SNDX 0.13%

SNGX 0.79%

SNPX -3.97%

SONN -4.75%

SPPI -0.49%

SPRB 0.49%

SPRC -2.02%

SPRO 3.13%

SRNE 20.00%

SRPT 0.55%

SRRA 0.00%

SRRK -0.34%

SRZN -1.70%

STAB 0.00%

STOK -0.26%

STRO 0.94%

STSA 0.00%

STTK 0.40%

SURF -0.93%

SVRA -0.78%

SWTX -3.64%

SYBX -0.63%

SYRS -2.63%

TALS -0.73%

TARA 0.41%

TARS 1.72%

TBPH -0.12%

TCBP 1.78%

TCDA 0.00%

TCON -1.47%

TCRR 0.00%

TCRT -3.13%

TCRX -1.21%

TECH 0.07%

TENX -3.43%

TERN 0.13%

TFFP -2.05%

TGTX 0.21%

THRX 0.12%

TIL -2.06%

TLC 0.00%

TLSA 0.66%

TNGX 0.43%

TNXP 0.67%

TNYA 0.00%

TPST 0.52%

TRDA -3.61%

TRVI -0.18%

TRVN -1.88%

TSHA -9.93%

TSVT 0.25%

TTNP 1.45%

TVTX -0.27%

TYRA -0.39%

UBX 0.72%

UNCY -0.11%

URGN -7.01%

UTHR 0.08%

VACC 11.36%

VALN -2.51%

VAXX -0.11%

VBIV 1.15%

VBLT -8.77%

VCEL 0.50%

VCNX -1.54%

VCYT -0.09%

VERA -0.08%

VERU 0.50%

VERV -1.33%

VIGL -2.75%

VINC 1.05%

VIR -0.87%

VIRI -5.41%

VIRX -6.84%

VKTX -0.50%

VLON -13.04%

VNDA 0.63%

VOR 0.85%

VRCA 0.00%

VRDN -0.74%

VRNA 0.00%

VRPX -14.72%

VRTX 0.03%

VSTM 0.29%

VTGN 1.46%

VTVT -0.10%

VTYX -0.36%

VXRT 6.60%

VYGR 0.10%

VYNE 2.16%

VYNT 7.78%

WINT 5.59%

WVE -0.67%

XBIO 6.75%

XBIT -0.66%

XCUR -0.65%

XENE 0.30%

XERS 0.00%

XFOR -0.54%

XLO 2.96%

XLRN 0.00%

XNCR -0.41%

XOMA 0.00%

XOMAO -0.56%

XOMAP -0.14%

XRTX 2.88%

YMAB -0.38%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.20%

ZNTL -25.48%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-05-17	Wood Steven D	Buy	3 100	Common Stock
2024-05-16	Flynn James P	Buy	7 900	Common Stock
2023-12-18	Flynn James P	Buy	10 000	Stock Option (Right to Buy)
2023-12-18	Flynn James P	Buy	6 700	Stock Option (Right to Buy)
2023-12-18	Wood Steven D	Buy	10 000	Stock Option (Right to Buy)

INSIDER POWER
91.06
Last 96 transactions
Buy: 9 843 993 \| Sell: 849 643

Koreliacija (AI algo v.1.1b): Overvalued: -2.17% $2.88 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

MEI Pharma Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
PACB	0.962
VVOS	0.956
WBA	0.95
MVST	0.95
EVOK	0.949
INVZ	0.948
FWRD	0.948
RIVN	0.945
OPEN	0.944
CFFI	0.942

10 Labiausiai neigiamai susiję koreliacijos
APXI	-0.94
ESTA	-0.936
DXJS	-0.929
ACGL	-0.928
OXSQ	-0.928
BSCO	-0.927
IBKR	-0.925
SWAV	-0.922
PNTG	-0.916
ADTH	-0.916

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

MEI Pharma Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$48.82M
Bruto pelnas:	$47.00M (96.28 %)
EPS:	$-4.78

FY	2023
Pajamos:	$48.82M
Bruto pelnas:	$47.00M (96.28 %)
EPS:	$-4.78

FY	2022
Pajamos:	$40.70M
Bruto pelnas:	$39.46M (96.97 %)
EPS:	$-8.80

FY	2021
Pajamos:	$25.54M
Bruto pelnas:	$24.13M (94.49 %)
EPS:	$-0.450

Financial Reports:

No articles found.

MEI Pharma Inc Dividends

(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$1.750 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

MEI Pharma Inc Dividend Information - Dividend Knight

Dividend Sustainability Score: 5.63 - average (54.68%) | Divividend Growth Potential Score: 0 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$1.750	2023-11-16
Last Dividend	$1.750	2023-11-16
Next Dividend	$0	N/A
Payout Date	2023-12-06
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$1.750	--
Avg. Dividend % Per Year	11.67%	--
Score	4.8	--
Div. Sustainability Score	5.63
Div.Growth Potential Score	0
Div. Directional Score	2.63	--

Next Divdend (Est)
(2024-06-18)

$3.50 Estimate 2.50 %

Dividend Stability

0.20 Very Poor

Dividend Score

4.80

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2023	$1.750	35.00%
2024	$0	0.00%

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
16 Nov 2023	$1.750	06 Nov 2023	17 Nov 2023	06 Dec 2023

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Diamond	2024-09-16	Monthly	14	15.03%	9.60
DMLP	Dividend Diamond	2024-04-26	Quarterly	22	10.71%	9.35
OXSQ	Dividend Diamond	2024-09-16	Monthly	21	12.73%	9.02
ARLP	Dividend Royal	2024-05-07	Quarterly	26	9.67%	8.87
PNNT	Dividend Royal	2024-06-14	Monthly	18	9.49%	8.82
MFIC	Dividend Royal	2024-06-11	Quarterly	21	10.89%	8.79
SPOK	Dividend Royal	2024-05-23	Quarterly	20	8.73%	8.72
PSEC	Dividend Royal	2024-06-25	Monthly	21	9.03%	8.65
SBLK	Dividend Royal	2024-06-06	Quarterly	17	13.10%	8.63
GBDC	Dividend Royal	2024-11-29	Bi-Monthly	15	8.53%	8.62

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.392	1.500	2.16	3.25	[0 - 0.5]
returnOnAssetsTTM	0.367	1.200	10.00	10.00	[0 - 0.3]
returnOnEquityTTM	0.483	1.500	5.74	8.61	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	6.17	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	5.88	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	0.246	1.500	9.74	10.00	[0.2 - 2]
debtRatioTTM	0.164	-1.500	7.27	-10.00	[0 - 0.6]
interestCoverageTTM	-1 726.31	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-6.57	2.00	-2.19	-4.38	[0 - 30]
freeCashFlowPerShareTTM	-6.57	2.00	-3.28	-6.57	[0 - 20]
debtEquityRatioTTM	0.229	-1.500	9.09	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.984	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.336	1.000	5.28	5.28	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-3.75	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0.937	0.800	7.09	5.67	[0.5 - 2]
Total Score				5.63

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	0.716	1.000	-0.0287	0	[1 - 100]
returnOnEquityTTM	0.483	2.50	7.26	8.61	[0.1 - 1.5]
freeCashFlowPerShareTTM	-6.57	2.00	-2.19	-6.57	[0 - 30]
dividendYielPercentageTTM	62.28	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-6.57	2.00	-2.19	-4.38	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.0171	1.500	-3.22	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.656	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-0.362

MEI Pharma Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

MEI Pharma Inc

MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymphoma, as well as in Phase Ib multi-arm trial to treat B-cell malignancies; and Voruciclib, an oral cyclin-dependent kinase 9 inhibitor, which is in Phase Ib clinical trial for acute myeloid leukemia and B-cell malignancies. It also develops ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex that is in Phase I clinical trial for the treatment of human epidermal growth factor receptor 2 negative breast cancer; and Pracinostat, an oral available histone deacetylase inhibitor, which is in Phase II clinical trial to treat patients with myelodysplastic syndrome. MEI Pharma, Inc. has a license, development, and commercialization agreement with Kyowa Kirin Company; a clinical collaboration with BeiGene, Ltd.; a license, development, manufacturing, and commercialization agreement with Helsinn Healthcare SA; and a license agreement with Presage Biosciences, Inc. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California.